Department of Veterans Affairs Awarded a Contract to UNITED THERAPEUTICS CORP for $16,514.15

Q: Where is UNITED THERAPEUTICS CORP located?

1040 SPRING ST SILVER SPRING MARYLAND UNITED STATES

Signed on

8/3/2025, 12:00 AM

UNITED THERAPEUTICS CORP Government Contract #36C24525N0839

UNITED THERAPEUTICS CORP was awarded a contract with the United States Government for $16,514.15. The contract was awarded by the agency office 245-NETWORK CONTRACT OFFICE 5 (36C245), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

The recipient of the federal contract is the United Therapeutics Corp, a U.S.-owned business specializing in pharmaceutical preparation manufacturing. The contract, funded by the Department of Veterans Affairs, is for Tyvaso 64 mcg kit, with a total obligation of $16,514.15. The contract was awarded via a delivery order, following full and open competition. One transaction of $16,514.15 was made on August 3, 2025, as part of this contract.

Contract Details

Contract ID36C24525N0839

Contract TypeC

Total Obligation$16,514.15

Exercised Options$16,514.15

Base Amount + Options$16,514.15

Date Signed2025-08-03

Contract DescriptionTYVASO 64 MCG KIT

Start Date2025-08-03

End Date2025-08-06

Agency Details

Awarding AgencyDepartment of Veterans Affairs

Awarding Sub AgencyDepartment of Veterans Affairs

Awarding Office245-NETWORK CONTRACT OFFICE 5 (36C245)

Funding AgencyDepartment of Veterans Affairs

Funding Sub AgencyDepartment of Veterans Affairs

Funding Office581 HUNTINGTON (00581)(36C581)

Recipient Details

RecipientUNITED THERAPEUTICS CORP

Recipient Location1040 SPRING ST SILVER SPRING MARYLAND, UNITED STATES

Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions

Transaction #0 | $16,514.15August 3, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $16,514.15 to UNITED THERAPEUTICS CORP. The payment included a Subsidy Cost of $0.00.